Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Rapport Therapeutics, Inc.(RAPP) | 7,135,233 | 6,280,525 | -854,708 | $223.26M | $261.71M | 52.53% | +$38.45M |
| Septerna, Inc.(SEPN) | 6,215,591 | 6,215,591 | 0 | $149.36M | $208.16M | 41.78% | +$58.80M |
| Maze Therapeutics, Inc.(MAZE) | 950,800 | 950,800 | 0 | $28.38M | $28.37M | 5.69% | -$9.5K |